Status:

COMPLETED

Chemotherapy With or Without Enoxaparin in Pancreatic Cancer

Lead Sponsor:

CONKO-Studiengruppe

Collaborating Sponsors:

Sanofi

Amgen

Conditions:

Pancreatic Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

To evaluate the safety and efficacy of chemotherapy with or without enoxaparin. This study is powered to decrease the DVT/ VTE events rate from 10% to 3% with enoxaparin in the experimental arm. N=54...

Detailed Description

Approximately 20% of patients (pts) diagnosed with pancreatic adenocarcinoma (PA) develop venous thromboembolism, which may contribute to the dismal prognosis of PA. A small phase II trial suggested a...

Eligibility Criteria

Inclusion

  • histological or cytological pancreatic carcinoma, stage IV A, b
  • no preceding radio or chemotherapy of the primarius or the reference lesions
  • Karnofsky performance status ≥ 60%
  • measurable tumor lesion by spiral CT or MRT not older than 14 days
  • no deep venous thrombosis within the last 2 years
  • patient compliance and geographical proximity of the residence, which make an adequate follow up possible
  • sufficient bone marrow reserve: leukocyte ≥ 3.5 × 109 /l, thrombocyte ≥ 100 × 109 /l
  • signed informed consent
  • minimum age of 18 years
  • women/men must provide sufficient pregnancy prevention

Exclusion

  • preexisting indication for anti-coagulation of other reason
  • bleeding in the last 2 weeks or increased bleeding risk (e.g. serious coagulating disturbance, active stomach or intestine ulzera, or had operational interferences in the last 2 weeks)
  • body weight \< 45 kg and/or \> 100 kg
  • pregnancy or insufficient preventing methods in the study process
  • serious illness, which are incompatible with a study participation
  • hypersensitivity to study drugs
  • patients with serious kidney malfunction (Creatininclearance \< 30 ml/min)

Key Trial Info

Start Date :

April 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2009

Estimated Enrollment :

312 Patients enrolled

Trial Details

Trial ID

NCT00785421

Start Date

April 1 2004

End Date

June 1 2009

Last Update

January 8 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universitätsmedizin - Berlin - Charite

Berlin, State of Berlin, Germany, 13353